Trichotillomania (Hair-Pulling Disorder)
8
1
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
Semaglutide (Wegovy) Treatment for Trichotillomania
Epidiolex in Obsessive Compulsive Disorder and Related Disorders
Efficacy of Valbenazine for the Treatment of Trichotillomania in Adults
Behavioral Treatment and Memantine in Body Focused Repetitive Behaviors
Aripiprazole in Body Focused Repetitive Behaviors
Memantine in Body Focused Repetitive Behaviors
Leveraging Technological Advancements to Improve the Treatment of Trichotillomania
Self-control and Body-focused Repetitive Behaviors